This brand name is authorized in Nigeria.
The drug LAPAR contains one active pharmaceutical ingredient (API):
1
|
UNII
362O9ITL9D - ACETAMINOPHEN
|
|
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| 04-4685 | Tablet | Lapar Tablets_ TAB 500 mg 1 x 1000's in Jar, 8 x 12's in Alu-PVC blister | Uncoated Tablet. White circular flat beveled-edge uncoated tablets, having embossed with ‘LAPAR/500’ on one side and other side is plain. 8 RNW-PP-400373 Lapar Tablets Paracetamol 500mg Paracetamol 500mg Starch B.P. 60mg Gelatin B.P. 6.66mg Propyl Paraben B.P. 0.40mg Starch B.P. 40mg Sodium Metabisulphite B.P 0.40mg Sorbitol B.P. 3mg Magnesium Stearate B.P. 1.80mg Apr-85 Drugs Nigerian Products 1X1000,8X12 OTC 1/19/2024 MECURE INDUSTRIES LIMITED, 18, SURAMOGAJISTREETILUPEJU, LAGOS, LAGOS, LAGOS, , LAGOS 12206062 pharma@mecure.com Mecure Industries Ltd, Debo Industries Compound, Plot 6, Block H, Oshodi Industrial Scheme, Oshodi, Lagos. , Nigeria | 31/07/2024 |
| A4-4824 | Syrup | Lapar Paracetamol Syrup SYRUP 125 mg 1 x 60 mL (in amber plastic bottle) | Syrup A clear light pink syrupy liquid having aromatic raspberry odor 56 Lapar A4-4824 Lapar Paracetamol Syrup Paracetamol, Sucrose Methyl Paraben, Propyl Paraben, Disodium Edta BP Analgesics Oral 125 mg Syrup Over The Counter (Otc) Me Cure Industries Ltd Me Cure Industries Ltd. Nigeria 01/03/2021 28/02/2026 | 01/03/2021 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| N02BE01 | Paracetamol | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | 04-4685, A4-0211, A4-4824 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.